| Guideline for the management of clinically localized prostate cancer: 2007 update I Thompson, JB Thrasher, G Aus, AL Burnett, ED Canby-Hagino, ... The Journal of urology 177 (6), 2106-2131, 2007 | 1168 | 2007 |
| Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized … MS Cookson, G Aus, AL Burnett, ED Canby-Hagino, AV D’Amico, ... The Journal of urology 177 (2), 540-545, 2007 | 566 | 2007 |
| A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity KF Card, SA Price-Schiavi, B Liu, E Thomson, E Nieves, H Belmont, ... Cancer Immunology, Immunotherapy 53 (4), 345-357, 2004 | 319 | 2004 |
| Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy JW Moul, H Wu, L Sun, DG McLeod, C Amling, T Donahue, L Kusuda, ... The Journal of urology 171 (3), 1141-1147, 2004 | 318 | 2004 |
| Prostate‐specific antigen: a review of the validation of the most commonly used cancer biomarker J Hernández, IM Thompson Cancer 101 (5), 894-904, 2004 | 308 | 2004 |
| Tolerance to p53 by A2. 1-restricted cytotoxic T lymphocytes M Theobald, J Biggs, J Hernández, J Lustgarten, C Labadie, LA Sherman Journal of Experimental Medicine 185 (5), 833-842, 1997 | 298 | 1997 |
| The association of body mass index and prostate‐specific antigen in a population‐based study J Baillargeon, BH Pollock, AR Kristal, P Bradshaw, J Hernandez, J Basler, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 261 | 2005 |
| Erectile function outcome reporting after clinically localized prostate cancer treatment AL Burnett, G Aus, ED Canby-Hagino, MS Cookson, AV D’Amico, ... The Journal of urology 178 (2), 597-601, 2007 | 229 | 2007 |
| Phenotypic and functional analysis of CD8+ T cells undergoing peripheral deletion in response to cross-presentation of self-antigen J Hernandez, S Aung, WL Redmond, LA Sherman Journal of Experimental Medicine 194 (6), 707-718, 2001 | 228 | 2001 |
| New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection E Domingo, J Diez, MA Martinez, J Hernández, A Holguin, B Borrego, ... Journal of General Virology 74 (10), 2039-2045, 1993 | 156 | 1993 |
| Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. MA Martinez, J Dopazo, J Hernandez, MG Mateu, F Sobrino, E Domingo, ... Journal of Virology 66 (6), 3557-3565, 1992 | 153 | 1992 |
| Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low-vs high-grade prostate cancer DP Ankerst, J Hoefler, S Bock, PJ Goodman, A Vickers, J Hernandez, ... Urology 83 (6), 1362-1368, 2014 | 148 | 2014 |
| Uncoupling of proliferative potential and gain of effector function by CD8+ T cells responding to self-antigens J Hernández, S Aung, K Marquardt, LA Sherman Journal of Experimental Medicine 196 (3), 323-333, 2002 | 147 | 2002 |
| The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope M Theobald, T Ruppert, U Kuckelkorn, J Hernandez, A Häussler, ... Journal of Experimental Medicine 188 (6), 1017-1028, 1998 | 143 | 1998 |
| Obesity, adipokines, and prostate cancer in a prospective population-based study J Baillargeon, EA Platz, DP Rose, BH Pollock, DP Ankerst, S Haffner, ... Cancer Epidemiology and Prevention Biomarkers 15 (7), 1331-1335, 2006 | 142 | 2006 |
| Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer H Roca, J Hernandez, S Weidner, RC McEachin, D Fuller, S Sud, ... PloS one 8 (10), e76773, 2013 | 135 | 2013 |
| The use of HLA A2. 1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire J Hernández, PP Lee, MM Davis, LA Sherman The Journal of Immunology 164 (2), 596-602, 2000 | 134 | 2000 |
| Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. MG Mateu, J Hernández, MA Martinez, D Feigelstock, S Lea, JJ Pérez, ... Journal of virology 68 (3), 1407-1417, 1994 | 128 | 1994 |
| Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2. 1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells J Hernández, F García-Pons, YC Lone, H Firat, JD Schmidt, ... Proceedings of the National Academy of Sciences 99 (19), 12275-12280, 2002 | 120 | 2002 |
| External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population DJ Parekh, DP Ankerst, BA Higgins, J Hernandez, E Canby-Hagino, ... Urology 68 (6), 1152-1155, 2006 | 116 | 2006 |
